Marinobufagenin causes endothelial cell monolayer hyperpermeability by altering apoptotic signaling

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 296, Issue 6, 2009, Pages

  Uddin, Mohammad N ^a   Horvat, Darijana ^a   Childs, Ed W ^a   Puschett, Jules B ^a,b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b Medical Education Bldg ^*  (United States)

Author keywords

catenin; Bufodienolide; Caspases; MAP kinase; Rat lung microvascular endothelial cells

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CASPASE INHIBITOR; LIPOCORTIN 5; MARINOBUFAGENIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL JUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; INHIBITION KINETICS; LUNG; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STAINING;

ADHERENS JUNCTIONS; ANIMALS; APOPTOSIS; BUFANOLIDES; CAPILLARY PERMEABILITY; CASPASES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG; MICROVESSELS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RATS; SIGNAL TRANSDUCTION; TIME FACTORS; UP-REGULATION;

EID: 67049115992     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.90963.2008     Document Type: Article

References (49)

1. +-pump in human mesenteric arteries. J Hypertens 16: 1953-1958, 1998.
2. Berra E, Diaz-Meco MT, Moscat J. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J Biol Chem 273: 10792-10797, 1998. (Pubitemid 28227697)
3. Cervello M, Giannitrapani L, La Rosa M, Notarbartolo M, Labozzetta M, Poma P, Montalto G, D'Alessandro N. Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation. Int J Mol Med 13: 741-748, 2004.
4. Chang L, Karin M. Mammalian MAP kinase signaling cascades. Nature 410: 37-40, 2001. (Pubitemid 32225829)
5. Chesley LC. Plasma and red cell volumes during pregnancy. Am J Obstet Gynecol 112: 440-450, 1972.
6. Childs EW, Tharakan B, Byrge N, Tinsley JH, Hunter FA, Smythe WR. Angiopoietin-1 inhibits intrinsic apoptotic signaling and vascular hyperpermeability following hemorrhagic shock. Am J Physiol Heart Circ Physiol 294: H2285-H2295, 2008.
7. Childs EW, Tharakan B, Hunter FA, Tinsley JH, Cao X. Apoptotic signaling induces hyperpermeability following hemorrhagic shock. Am J Physiol Heart Circ Physiol 292: H3179-H3189, 2007. (Pubitemid 47084574)
8. Chuang SM, Wang IC, Yang JL. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium. Carcinogenesis 21: 1423-1432, 2000. (Pubitemid 30456003)
9. Cory AH, Owen TC, Barltrop JA, Cory JG. Use of an aqueous soluble tetrazolium/formazen assay for cell growth assays in culture. Cancer Commun 3: 207-212, 1991.
10. Davidson MT, Deitch EA, Lu Q, Hasko G, Abungu B, Nemeth ZH, Zaets SB, Gaspers LD, Thomas AP, Xu DZ. Trauma-hemorrhagic shock mesenteric lymph induces endothelial apoptosis that involves both caspase-dependent and caspase-independent mechanisms. Ann Surg 240: 123-131, 2004. (Pubitemid 38808244)
11. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252, 2000.
12. Durst J, Vu HV, Ianosi-Irimie MR, Pridjian CA, Bagrov A, Fedorova OV, Pridjian G, Puschett JB. Antibodies to marinobufagenin reduce blood pressure in a rat model of preeclampsia. J Investig Med 52: S318, 2004.
13. Fedorova OV, Kolodkin NI, Agalakova NI, Lakatta EG, Bagrov AY. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats. Hypertension 37: 462-466, 2001. (Pubitemid 32199012)
14. Fisher SJ. The placental problem: Linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol 2: 53, 2004. (Pubitemid 39130526)
15. Gautam N, Herwald H, Hedqvist P, Lindbom L. Signaling via beta (2) integrins triggers neutrophil-dependent alteration in endothelial barrier function. J Exp Med 191: 1829-1839, 2000.
16. Gonick HC, Ding Y, Vaziri ND, Bagrov AY, Fedorova OV. Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. Clin Exp Hypertens 20: 617-627, 1998. (Pubitemid 28319534)
17. Gregorc U, Ivanova S, Thomas M, Turk V, Banks L, Turk B. hDLG/SAP97, a member of the MAGUK protein family, is a novel caspase target during cell-cell detachment in apoptosis. Biol Chem 386: 705-710, 2005. (Pubitemid 41448173)
18. Hays PM, Cruikshank DP, Dunn LJ. Plasma volume determination in normal and preeclamptic pregnancies. Am J Obstet Gynecol 151: 958-966, 1985. (Pubitemid 15237734)
19. Ianosi-Irimie MR, Vu HV, Whitbred JM, Pridjian CA, Nadig JD, Williams MY, Wrenn DC, Pridjian G, Puschett JB. A rat model of preeclampsia. Clin Exp Hypertens 8: 605-617, 2005. (Pubitemid 41722067)
20. Jalali S, Li YS, Sotoudeh M, Yuan S, Li S, Chien S, Shyy JY. Shear stress activates p60src-Ras-MAPK signaling pathways in vascular endothelial cells. Arterioscler Thromb Vasc Biol 18: 227-234, 1998. (Pubitemid 28277599)
21. Kavinen J, Hurkainen P, Gopalakrishnan S, Burns D, Warrior U, Hemmila I. Homogeneous time-resolved fluorescence quenching assay (LANCE) for caspase-3. J Biomol Screen 7: 223-231, 2002. (Pubitemid 34734331)
22. LaMarca HL, Morris CA, Pettit GR, Nagowa T, Puschett JB. Marinobufagenin impairs first trimester cytotrophoblast differentiation. Placenta 27: 984-988, 2006. (Pubitemid 44204032)
23. Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA, Bagrov AY. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens 17: 1179-1187, 1999. (Pubitemid 29389566)
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983. (Pubitemid 14203433)
25. Nakamoto K, Kuratsu J, Ozawa M. Beta-catenin cleavage in non-apoptotic cells with reduced cell adhesion activity. Int J Mol Med 15: 973-979, 2005.
26. Nasu K, Nishida M, Ueda T, Takai N, Bing S, Narahara H, Miyakawa I. Bufalin induces apoptosis and the G0/G1 cell cycle arrest of endometriotic stromal cells: a promising agent for the treatment of endometriosis. Mol Hum Reprod 11: 817-823, 2005. (Pubitemid 43205490)
27. Nebreda AR, Porras A. p38 MAP kinases: beyond the stress response. Trends Biochem Sci 25: 257-260, 2000. (Pubitemid 30333380)
28. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995.
29. Pamnani MB, Chen S, Yuan CM, Haddy FJ. Chronic blood pressure effects of bufalin, a sodium-potassium ATPase inhibitor, in rats. Hypertension 23: I106-109, 1994. (Pubitemid 24020430)
30. Pridjian G, Puschett JB. Preeclampsia Part 1: Clinical and pathophysiological considerations. Obstet Gynecol Surv 57: 598-618, 2002. (Pubitemid 34977665)
31. Pridjian G, Puschett JB. Preeclampsia Part 2: Experimental and genetic considerations. Obstet Gynecol Surv 57: 619-640, 2002. (Pubitemid 34977666)
32. Readline RW, Patterson P. Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum Pathol 26: 594-600, 1995.
33. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341: 1447-1451, 1993. (Pubitemid 23161452)
34. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161: 1200-1204, 1989. (Pubitemid 20007682)
35. Schmidt-Ullrich RK, Dent P, Grant S, Mikkelsen RB, Valerie K. Signal transduction and cellular radiation responses. Radiat Res 153: 245-257, 2000. (Pubitemid 30224838)
36. Schoner W. Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem 269: 2440-2448, 2002. (Pubitemid 34539271)
37. Svedas E, Islam KB, Nisell H, Kublickiene KR. Vascular endothelial growth factor induced functional and morphologic signs of endothelial dysfunction in isolated arteries from normal pregnant women. Am J Obstet Gynecol 188: 168-176, 2003. (Pubitemid 36135615)
38. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 81: 801-809, 1995.
39. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 281: 1312-1316, 1998. (Pubitemid 28406817)
40. Tinsley JH, Wu MH, Ma W, Taulman AC, Yuan SY. Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells. J Biol Chem 274: 24930-24934, 1999. (Pubitemid 129529383)
41. Uddin MN, McLean LB, Hunter FA, Horvat D, Severson J, Tharakan B, Childs EW, Puschett JB. Vascular leak in a rat model of preeclampsia. Am J Nephrol 30: 26-33, 2009.
42. Uddin MN, Horvat D, Glaser SS, Mitchell BM, Puschett JB. Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblast function. J Biol Chem 283: 17946-17953, 2008.
43. Uddin MN, Horvat D, Glaser SS, Danchuk S, Mitchell BM, Sullivan DE, Morris CA, Puschett JB. Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells. Placenta 29: 266-273, 2008.
44. van Engeland M, Ramaekers FC, Schutte B, Reutelingsperger CP. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24: 131-139, 1996. (Pubitemid 26202924)
45. Versteeg HH, Nijhuis E, van den Brink GR, Evertzen M, Pynaert GN, van Deventer SJ, Coffer PJ, Peppelenbosch MP. A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B, and cAMP-response-element-binding protein. Biochem J 350: 717-722, 2000.
46. Vu HV, Ianosi-Irimie MR, Pridjian CA, Whitbred JM, Durst JM, Bagrov AY, Fedorova OV, Pridjian G, Puschett JB. The involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol 25: 520-528, 2005. (Pubitemid 41433898)
47. Wang Y, Adair CD, Weeks JW, Lewis DF, Alexander JS. Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia. J Soc Gynecol Investig 6: 136-141, 1999. (Pubitemid 29264902)
48. Wang Y, Gu Y, Granger DN, Roberts JM, Alexander JS. Endothelial junctional protein redistribution and increased monolayer permeability in human umbilical vein endothelial cells isolated during preeclampsia. Am J Obstet Gynecol 186: 214-220, 2002. (Pubitemid 34165436)
49. Watts JA, Grattan RM, Whitlow BS, Kline JA. Activation of poly (ADP-ribose) polymerase in severe hemorrhagic shock and resuscitation. Am J Physiol Gastrointest Liver Physiol 281: G498-G506, 2001. (Pubitemid 32751325)